Morton Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Sell
905
-572
-39% -$584K 0.15% 49
2026
Q1
$1.36M Buy
1,477
+706
+92% +$716K 0.2% 40
2025
Q4
$829K Buy
771
+11
+1% +$10.5K 0.13% 49
2025
Q3
$580K Sell
760
-110
-13% -$81.9K 0.1% 66
2025
Q2
$678K Buy
870
+114
+15% +$88.6K 0.12% 57
2025
Q1
$625K Buy
756
+36
+5% +$30K 0.12% 59
2024
Q4
$556K Hold
720
0.1% 65
2024
Q3
$638K Buy
720
+302
+72% +$272K 0.13% 58
2024
Q2
$378K Sell
418
-24
-5% -$19.2K 0.09% 69
2024
Q1
$344K Buy
442
+20
+5% +$14.2K 0.09% 71
2023
Q4
$246K Buy
422
+22
+6% +$12.8K 0.07% 86
2023
Q3
$215K Sell
400
-39
-9% -$20.1K 0.08% 85
2023
Q2
$206K Buy
+439
New +$184K 0.07% 89

Other funds holding LLY

Morton Capital Management's LLY Position: Q2 2026 in Review

Morton Capital Management reduced its Eli Lilly (LLY) stake by 39% in Q2 2026, selling an estimated $584K and leaving 905 shares worth $1.09M. The position accounts for 0.15% of the portfolio, ranked #49.

Morton Capital Management first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.36M in Q1 2026. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Morton Capital Management held 905 shares of Eli Lilly worth $1.09M as of Q2 2026.
  • Morton Capital Management sold 572 Eli Lilly shares in Q2 2026, an estimated $584K.
  • Eli Lilly made up 0.15% of Morton Capital Management's portfolio in Q2 2026, its #49 holding.
  • Morton Capital Management first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • Morton Capital Management's Eli Lilly position peaked at $1.36M in Q1 2026.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Morton Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.